In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria.
Cassano
N
N
Filotico
R
R
D'Argento
V
V
Filieri
M
M
Coviello
C
C
Vena
Ga
G
D000293:Adolescent; D000328:Adult; D001707:Biopsy, Needle; D016022:Case-Control Studies; D002908:Chronic Disease; D046508:Culture Techniques; D019040:E-Selectin / Q000032:analysis / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011336:Probability; D011446:Prospective Studies; D012016:Reference Values; D012720:Severity of Illness Index; D016593:Terfenadine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy* / Q000473:pathology; D019010:Vascular Cell Adhesion Molecule-1 / Q000032:analysis / Q000187:drug effects*
D019040:E-Selectin; D019010:Vascular Cell Adhesion Molecule-1; D016593:Terfenadine; C093230:fexofenadine